PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
23292117-9	2013	Additionally, 50 and 100 mumol/L of EGCG significantly reduced the secretion of VEGF and IL-8 proteins induced by HPV-16 E7 oncoprotein in NSCLC A549 cells.	epigallocatechin gallate	36-40	vascular endothelial growth factor A	Mus musculus	80-84	
23292117-11	2013	Furthermore, EGCG inhibited HPV-16 oncoprotein-induced HIF-1alpha and HIF-1alpha-dependent VEGF and CD31 expression in A549 xenografted tumors.	epigallocatechin gallate	13-17	vascular endothelial growth factor A	Mus musculus	91-95	
23292117-12	2013	CONCLUSIONS: EGCG inhibited HPV-16 oncoprotein-induced angiogenesis conferred by NSCLC through the inhibition of HIF-1alpha protein expression and HIF-1alpha-dependent expression of VEGF, IL-8, and CD31 as well as activation of Akt, suggesting that HIF-1alpha may be a potential target of EGCG against HPV-related NSCLC angiogenesis.	epigallocatechin gallate	13-17	vascular endothelial growth factor A	Mus musculus	182-186